Justin C. Zhang

Justin C. Zhang

Auto-generated profile, based on publicly available information

Justin C. Zhang

Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JRJoseph S. Reiff
Joseph S. Reiff
JZJustin C. Zhang
Justin C. Zhang
JGJana Gallus
Jana Gallus
HDHengchen Dai
Hengchen Dai
NPNathaniel M. Pedley
Nathaniel M. Pedley
DCDaniel M. Croymans
Daniel M. Croymans
Policymakers and business leaders often use peer comparison information—showing people how their behavior compares to that of their peers—to motivate a range of behaviors. Despite their widespread use, the potential impact of peer comparison interventions on recipients’ well-being is largely unknown. We conducted a 5-mo field experiment involving 199 primary care physicians and 46,631 patients to examine the impact of a peer comparison intervention on physicians’ job performance, job satisfaction, and burnout. We varied whether physicians received information about their preventive care performance compared to that of other physicians in the same health system. Our analyses reveal that our implementation of peer comparison did not significantly improve physicians’ preventive care performance, but it did significantly decrease job satisfaction and increase burnout, with the effect on job satisfaction persisting for at least 4 mo after the intervention had been discontinued. Quantitative and qualitative evidence on the mechanisms underlying these unanticipated negative effects suggest that the intervention inadvertently signaled a lack of support from leadership. Consistent with this account, providing leaders with training on how to support physicians mitigated the negative effects on well-being. Our research uncovers a critical potential downside of peer comparison interventions, highlights the importance of evaluating the psychological costs of behavioral interventions, and points to how a complementary intervention—leadership support training—can mitigate these costs.

2 February 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JZJustin C. Zhang
Justin C. Zhang
KCKatherine L. Christensen
Katherine L. Christensen
RLRichard K. Leuchter
Richard K. Leuchter
SVSitaram Vangala
Sitaram Vangala
MHMaria Han
Maria Han
DCDaniel M. Croymans
Daniel M. Croymans
Background: Little information exists on how COVID-19 testing influences intentions to engage in risky behavior. Understanding the behavioral effects of diagnostic testing may highlight the role of adequate testing on controlling viral transmission. In order to evaluate these effects, simulated scenarios were conducted evaluating participant intentions to self-isolate based on COVID-19 diagnostic testing availability and results. Methods: Participants from the United States were recruited through an online survey platform (Amazon Mechanical Turk) and randomized to one of three hypothetical scenarios. Each scenario asked participants to imagine having symptoms consistent with COVID-19 along with a clinical diagnosis from their physician. However, scenarios differed in either testing availability (testing available v. unavailable) or testing result (positive v. negative test). The primary outcome was intention to engage in high-risk COVID-19 behaviors, measured using an 11-item mean score (range 1–7) that was pre-registered prior to data collection. Multi-variable linear regression was used to compare the mean composite scores between conditions. The randomized survey was conducted between July 23rd to July 29th, 2020. Results: A total of 1400 participants were recruited through a national, online, opt-in survey. Out of 1194 respondents (41.6% male, 58.4% female) with a median age of 38.5 years, participants who had no testing available in their clinical scenario showed significantly greater intentions to engage in behavior facilitating COVID-19 transmission compared to those who received a positive confirmatory test result scenario (mean absolute difference (SE): 0.14 (0.06), P = 0.016), equating to an 11.1% increase in mean score risky behavior intentions. Intention to engage in behaviors that can spread COVID-19 were also positively associated with male gender, poor health status, and Republican party affiliation. Conclusion: Testing availability appears to play an independent role in influencing behaviors facilitating COVID-19 transmission. Such findings shed light on the possible negative externalities of testing unavailability. Trial registration: Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance, NCT04459520, https://clinicaltrials.gov/ct2/show/NCT04459520.

1 January 2023 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
PDF file
NYNeal Yuan
Neal Yuan
JZJustin Zhang
Justin Zhang
RKRakan Khaki
Rakan Khaki
DLDerek Leong
Derek Leong
CBChandrashekhar Bhoopalam
Chandrashekhar Bhoopalam
JEJoseph E. Ebinger
Joseph E. Ebinger
Background: Contrast-associated acute kidney injury (CA-AKI) after percutaneous coronary intervention is associated with increased mortality. We assessed the effectiveness of an electronic health records safe contrast limit tool in predicting CA-AKI risk and reducing contrast use and CA-AKI. Methods: We created an alert displaying the safe contrast limit to cardiac catheterization laboratory staff prior to percutaneous coronary intervention. The alert used risk factors automatically extracted from the electronic health records. We included procedures from June 1, 2020 to October 1, 2021; the intervention went live February 10, 2021. Using difference-in-differences analysis, we evaluated changes in contrast volume and CA-AKI rates after contrast limit tool implementation compared to control hospitals. Cardiologists were surveyed prior to and 9 months after alert implementation on beliefs, practice patterns, and safe contrast estimates for example patients. Results: At the one intervention site, there were 508 percutaneous coronary interventions before and 531 after tool deployment. At 15 control sites, there were 3550 and 3979 percutaneous coronary interventions, respectively. The contrast limit predicted CA-AKI with an accuracy of 64.1%, negative predictive value of 93.3%, and positive predictive value of 18.7%. After implementation, in high/modifiable risk patients (defined as having a calculated contrast limit <500ml) there was a small but significant −4.60 mL/month (95% CI, −8.24 to −1.00) change in average contrast use but no change in CA-AKI rates (odds ratio, 0.96 [95% CI, 0.84–1.10]). Low-risk patients had no change in contrast use (−0.50 mL/month [95% CI, –7.49 to 6.49]) or CA-AKI (odds ratio, 1.24 [95% CI, 0.79–1.93]). In assessing CA-AKI risk, clinicians heavily weighted age and diabetes but often did not consider anemia, cardiogenic shock, and heart failure. Conclusions: Clinicians often used a simplified assessment of CA-AKI risk that did not include important risk factors, leading to risk estimations inconsistent with established models. Despite clinician skepticism, an electronic health records–based contrast limit tool more accurately predicted CA-AKI risk and was associated with a small decrease in contrast use during percutaneous coronary intervention but no change in CA-AKI rates.

23 January 2026 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
JZJustin C Zhang
Justin C Zhang
MWMelanie F Weingart
Melanie F Weingart
AMAdali Martinez
Adali Martinez
MWMark Wilson
Mark Wilson
JLJanice Louie
Janice Louie
DYDiana H Yu
Diana H Yu

16 May 2026 in The Joint Commission Journal on Quality and Patient Safety
Verified
Journal Article
Closed access
PAPriyanka Athavale
Priyanka Athavale
JZJustin C. Zhang
Justin C. Zhang
TSTamara Sanchez-Ortiz
Tamara Sanchez-Ortiz
LPLillian Peng
Lillian Peng
MAMaham Awan
Maham Awan
JHJames D. Harrison
James D. Harrison

16 July 2026 in Journal of General Internal Medicine
Verified
Journal Article
Open access
JZJustin C. Zhang
Justin C. Zhang
NBNirav R. Bhakta
Nirav R. Bhakta
MCMadeline Chicas
Madeline Chicas
AMAnoop Muniyappa
Anoop Muniyappa
SKSarah Kohut
Sarah Kohut
AEAida Venado Estrada
Aida Venado Estrada
Background: While continuous pulse oximetry monitoring (CPO) is ubiquitous in hospital settings, overutilization may contribute to alarm fatigue, disproportionately burdening bedside nurses and monitoring technicians. Achieving appropriate utilization remains a national patient safety goal. Objective: We investigated whether an electronic health record (EHR)–based quality improvement (QI) effort could safely reduce inpatient CPO monitoring. Intervention: This QI intervention took place from June 2022 to May 2024 across all non-ICU inpatient units of a 796-bed tertiary medical center. Following semi-structured interviews to understand CPO ordering practices, we implemented a revised CPO order, admission and discharge order sets, and new best practice advisory (BPA) to promote timely discontinuation. Main Measures: The primary outcome was change in monthly CPO hours using interrupted time series analysis comparing pre-intervention (June 2022–May 2023) and post-intervention (June 2023–May 2024) periods. Secondary outcomes included average monthly CPO alarms and CPO duration per admission, along with rate of escalation-of-care and serious patient harm events. Key Results: There were 18,351 CPO-associated hospitalizations during the pre-intervention period and 18,713 in the post-intervention period. Compared to the pre-intervention monthly average of 120,771 CPO hours, the post-intervention period was associated with an immediate reduction of 22,680 h (95% CI −33,591, −11,769; p < 0.01). Monthly CPO alarms (−332,819; 95% CI −510,870, −154,769; p < 0.01) and CPO duration per admission (−34.2 h; 95% CI −45.5, −22.9; p < 0.01) decreased during the post-implementation period. ICU transfer rates (+9.6 per 1000 admissions; 95% CI 0.87, 18.3; p = 0.03) increased without changes in rates of rapid responses, code blue events, nor mortality. Conclusion: An EHR-based QI initiative achieved significant, sustained reductions in CPO utilization, exemplifying how clinical decision support interventions can effectively reduce CPO utilization without increasing serious patient harm events in the form of code blue events or in-hospital mortality.